Fennec Pharmaceuticals Inc(FRX-T)
TSX

Today's Change
Real-Time Last Update

Fennec Pharmaceuticals Inc

68 TW Alexander Drive
PO Box 13628
Research Triangle Park NC 27709 USA
P: 919-636-4530
https://www.fennecpharma.com

Sectors & Indices

Sector
Industry
Employees

Profile

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Key Executives

NameTitle
Robert AndradeCFO/Chief Accounting Officer
Jeffrey S. HackmanCEO/Director
Pierre S. SayadChief Medical Officer

More from The Globe

Dye & Durham dumps CEO, Tyler Proud now leads company through board committee
The Bay Street financial district of Toronto is shown on Sunday Sept. 8, 2024. THE CANADIAN PRESS/Doug Ives
number cruncher
Searching for European momentum stocks in a frothy market
For Number Cruncher column in Globe Investor/ROB only.
Bullish potential on Intact Financial Corp.
Monica Rizk
top links
Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
Future headquarters of Ontario Power Generation, Oshawa, March 2025.
trade secrets
Where will tech stocks go from here?
Happy man investor. Crypto currency up trend. Growth chart concept. Trade Chart. Cryptocurrency mining, bitcoin exchange, blockchain and marketing technology, internet money flat vector illustration.
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored
Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
the mover
Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.